Curis, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcript
Curis, Inc. misses on earnings expectations. Reported EPS is $-2.03 EPS, expectations were $-1.91. Curis, Inc.
Curis Inc (CRIS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Maverick Capital Lee Ainslie | 582,273 | $7,423,981 | 0.14% | |
| 2. | M28 Capital Marc Elia | 421,951 | $5,379,875 | 4.45% | |
| 3. | Kingdon Capital Mark Kingdon | 284,150 | $3,622,913 | -9% | 0.45% |
| 4. | Renaissance Technologies Jim Simons | 90,163 | $1,150,000 | +6% | 0% |
| 5. | Alyeska Investment Group Anand Parekh | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 25,000 | Director | 51,596 | 2017-11-16 | Filing | |
| $1.06 | 50,000 | Officer, Director | 115,890 | 2017-11-15 | Filing | |
| $2.40 | 10,208,333 | Large Shareholder | 27,328,464 | 2016-09-07 | Filing | |
| $1.60 | 62,890 | Officer, Director | 65,890 | 2014-08-27 | Filing | |
| $2.52 | 3,000 | Officer | 3,000 | 2013-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.07 | 3,094 | Officer, Director | 64,877 | 2022-01-31 | Filing | |
| $3.18 | 2,406 | Officer, Director | 67,971 | 2022-01-27 | Filing | |
| $10.59 | 3,094 | Officer, Director | 67,268 | 2021-01-26 | Filing | |
| $10.96 | 2,283 | Officer, Director | 70,362 | 2021-01-25 | Filing | |
| $1.64 | 3,094 | Officer, Director | 42,158 | 2020-01-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 218,600 | $2,787,150 | 0% | |
| 2. | 208,476 | $2,658,069 | 0% | |
| 3. | 197,600 | $2,519,400 | 0% | |
| 4. | 91,872 | $1,171,368 | 0% | |
| 5. | 62,682 | $799,373 | 0% |
News See All
Curis, Inc. (NASDAQ:CRIS) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Curis' Third Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Curis’ Second Quarter 2023 Business Update Call. All participants will be in a listen-only mode.
Curis, Inc. (NASDAQ:CRIS) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis First Quarter 2023 Business Update Call. Please note, this event is being recorded.
Curis, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Curis Fourth Quarter 2022 Business Update Call. Please note, this event is being recorded.
5 Stocks to Invest In Under $20 According to Michael Castor's Sio Capital
In this piece, we will take a look at the five stocks to invest in under $20 according to Sio Capital.
5 Best Biotech Stocks Under $5
Agenus Inc. (NASDAQ:AGEN) is a clinical-stage immuno-oncology company based in Lexington, Massachusetts.
10 Healthcare Stocks to Buy According to Lee Ainslie's Maverick Capital
In this piece, we will take a look at the ten healthcare stocks to buy according to Lee Ainslie's Maverick Capital.
Do Hedge Funds Love Curis, Inc. (CRIS)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
